In cancer, alterations affecting the glycosylation machinery trigger the expression of immature and truncated O-glycans, such as Tn antigen, and its sialylated form, STn (NeuAcα2-6-GalNAcα1-O-Ser/Thr) [13]. This evidence concerns the gene EEF1A2 and cancer.